Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec;10(8):e259.
doi: 10.1002/ctm2.259.

Clinical efficacy of convalescent plasma therapy on treating COVID-19 patients: Evidence from matched study and a meta-analysis

Weijun Jiang  1 , Weiwei Li  1 , Lei Xiong  1 , Qiuyue Wu  1 , Jian Wu  1 , Bangshun He  1   2 , Jiawei Shen  1 , Rongrong Pang  1   3 , Tao Luo  1 , Yanju Guo  1 , Yang Yang  1 , Ying Han  1 , Wei Dai  1 , Peiran Zhu  1 , Xinyi Xia  1   4   5
Affiliations

Clinical efficacy of convalescent plasma therapy on treating COVID-19 patients: Evidence from matched study and a meta-analysis

Weijun Jiang et al. Clin Transl Med. 2020 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest.

Figures

FIGURE 1
FIGURE 1
The basic characteristics of all participants and the association between CPT and the rate of mortality. (A‐E) The basic characteristics of all participants. (A) Days of hospital stay in case with CPT groups and matched control group. (B) Days of hospital stay in case and control under severity subgroup. (C) Distribution of male and female in case with CPT groups and matched control group. (D) Age distribution in case with CPT groups and matched control group under severity subgroup. (E) Age distribution in case with CPT groups and matched control group under gender subgroup, *P < .05 (Student's t‐test). (F–N) The association between CPT and the rate of mortality. (F) Forest plot for overall analysis. (G) Forest plot for race subgroup analysis. (H) Design subgroup analysis. (I) Forest plot for severity subgroup analysis. (J) Forest plot for dose of CPT subgroup analysis. (K) Forest plot for article states subgroup analysis. (L) Forest plot for case size subgroup analysis. (M) The funnel plot for the association between CPT and the rate of mortality. (N) Trial sequential analysis of CPT and the rate of mortality
FIGURE 2
FIGURE 2
The association between CPT and risk of adverse events. (A‐G) Forest plot for the association between CPT and risk of adverse events. (A) Overall analysis. (B) Race subgroup analysis. (C) Design subgroup analysis. (D) Severity subgroup analysis. (E) Dose of CPT subgroup analysis. (F) Article states subgroup analysis. (G) Case size subgroup analysis. (H) The funnel plot for the association between CPT and risk of adverse events. (I) Trial sequential analysis of CPT and risk of adverse events
See this image and copyright information in PMC

References

    1. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708‐1720. - PMC - PubMed
    1. Hegerova L, Gooley TA, Sweerus KA, et al. Use of convalescent plasma in hospitalized patients with COVID‐19: case series. Blood. 2020;136(6):759‐762. - PMC - PubMed
    1. Liu STH, Lin H‐M, Baine I, et al. Convalescent plasma treatment of severe COVID‐19: a matched control study. medRxiv. 2020. https://doi.org/10.1101/2020.05.20.20102236
    1. Li L, Zhang W, Hu Y, Tong X, et al. Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life‐threatening COVID‐19: a randomized clinical trial. JAMA. 2020;324(5):460‐470. - PMC - PubMed
    1. Abolghasemi H, Eshghi P, Cheraghali AM, et al. Clinical efficacy of convalescent plasma for treatment of COVID‐19 infections: results of a multicenter clinical study. Transfus Apher Sci. 2020:102875. - PMC - PubMed

LinkOut - more resources